Companies: 10,795·Total market cap: $144.5T
Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd.

OPHLYOTCHealthcare● Active
$4.63
+$0.08(+1.76%)
Market Cap$6.5B
P/E Ratio—
52W High$5.75
52W Low$3.35
Overview
股票排行：Drug Manufacturers - General·Healthcare·查看全部市值排行 →

Ono Pharmaceutical Co., Ltd.（OPHLY）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · OPHLY · 截至 Jun 9, 2026

关键指标

EPS (TTM)$49.98ophly eps ttm · ophly earnings per shareEarnings history
PE Ratio (TTM)0.1×ophly pe ratio ttm · ophly price to earningsPE Ratio deep dive
Revenue (TTM)$522.8Bophly revenue ttm · ophly annual revenueFull revenue history
Dividend Yield6.45%does ophly pay dividends · ophly dividend yieldDividend history
Shares Outstanding1.41Bophly shares outstanding · ophly floatShares outstanding history
Next EarningsAug 3, 2026Est.ophly earnings date · ophly next earningsEarnings history

探索 Ono Pharmaceutical Co., Ltd. 数据

ophly stock data · financials
市值$6.5Bophly market cap · ophly valuation
分析师预测$— · Sell
股息6.45%does ono pharmaceutical co., ltd. pay dividends · ophly dividend yield
营收$546.9B+12.33%ono pharmaceutical co., ltd. annual revenue · ophly revenue
盈利EPS $52.73+48.45%ophly earnings · ophly eps
市盈率0.1×ophly pe ratio · ophly price to earnings

财务快照

完整财报
FY 2026Revenue$546.89B▲ +12.33% YoY
202420252026
ono pharmaceutical co., ltd. revenue · ophly revenue 2026
FY 2026Net Income$73.97B▲ +47.81% YoY
202420252026
ono pharmaceutical co., ltd. net income · ophly profit 2026
FY 2026EPS$52.73▲ +48.45% YoY
202420252026
ophly eps · ono pharmaceutical co., ltd. earnings per share 2026
TTM:Revenue: $522.75BNet Income: $70.78BEPS: $49.98View income statement →

分析师评级与目标价

完整预测
SellBuy
Sell2 位分析师is ophly a buy · ophly analyst rating
Strong Buy
0
Buy
0
Hold
0
Sell
2
Strong Sell
0
12-Month Price Target
$—Low
$4.63Current
$—Avg Target
$—High
ophly price target · ophly 12 month forecast

合计: 2 · 买入占比: 0.0%

股票表现

完整历史
1D+1.76%
1W+3.58%
1M-11.47%
3M-11.81%
YTD+1.76%
1Y+33.05%
5Y-36.92%

关于 Ono Pharmaceutical Co., Ltd.

CEOGyo Sagara
IPO DateOct 2, 2012
Employees3,853
CountryJP
Websiteono-pharma.com

Ono Pharmaceutical Co., Ltd. along with its subsidiaries, operates globally, engaging in the research, development, procurement, and commercialization of pharmaceutical products and diagnostic reagen…

Drug Manufacturers - GeneralHealthcareOTCADRJP

what is ono pharmaceutical co., ltd. · ophly stock overview · ono pharmaceutical co., ltd. company profile · who is ono pharmaceutical co., ltd. ceo · ophly OTC · ono pharmaceutical co., ltd. headquarters · ono pharmaceutical co., ltd. business segments

关于股票概览与关键数据

Ono Pharmaceutical Co., Ltd.（OPHLY）是 Drug Manufacturers - General 行业的 Healthcare 类公司，于 Oct 2, 2012 在 OTC 上市。截至最近交易日，OPHLY 股价为 $4.63，市值约为 $6.5B。过去12个月累计回报 +33.05%，年初至今回报 +1.76%。

根据 2 位华尔街分析师，Ono Pharmaceutical Co., Ltd. 股票共识评级为Sell，12个月平均目标价为 $—。2026 财年 Ono Pharmaceutical Co., Ltd. 营收 $546.9B，净利润 $74.0B。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Ono Pharmaceutical Co., Ltd.（OPHLY）股价为 $4.63，在 OTC 上市，52周区间为 $3.35 – $5.75。

OPHLY 最新股价OPHLY quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议